Receptor-binding domain-associated serotypes of SARS-CoV-2

Zezhong LiuKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, School of Pharmacy, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Lu LuKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, School of Pharmacy, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information

Shibo JiangKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, School of Pharmacy, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Click to increase image sizeClick to decrease image size

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

Z.L. is supported by the National Key Research and Development Program of China (2022YFC2305800). S.J., L.L. and Z.L. are supported by grants from the National Natural Science Foundation of China [92169112, 82041036 and 82202490].

Receptor-binding domain-associated serotypes of SARS-CoV-2

Information for

Open access

Opportunities

Help and information

Receptor-binding domain-associated serotypes of SARS-CoV-2

Disclosure statement

Additional information

Funding

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature